Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Capital Employed (2019 - 2025)

Bicycle Therapeutics' Return on Capital Employed history spans 7 years, with the latest figure at 0.08% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 15.0% year-over-year to 0.08%; the TTM value through Dec 2025 reached 0.08%, up 15.0%, while the annual FY2025 figure was 0.07%, 23.0% up from the prior year.
  • Return on Capital Employed reached 0.08% in Q4 2025 per BCYC's latest filing, up from 0.4% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.08% in Q4 2025 to a low of 0.4% in Q3 2025.
  • Average Return on Capital Employed over 5 years is 0.29%, with a median of 0.3% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: rose 17bps in 2021, then dropped -20bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.19% in 2021, then crashed by -70bps to 0.32% in 2022, then dropped by -7bps to 0.35% in 2023, then soared by 33bps to 0.23% in 2024, then surged by 65bps to 0.08% in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Return on Capital Employed are 0.08% (Q4 2025), 0.4% (Q3 2025), and 0.37% (Q2 2025).